Infinity Bio, Inc

Infinity Bio is a technology company that provides detailed insights into the immune system using its proprietary antibody profiling platform. The companys core technology comprehensively measures the antibody reactome, revealing the targets of individual immune responses against all known human viruses, human proteins (autoimmunity), and allergen proteins. Infinitys assay, MIPSA, was developed at Johns Hopkins University in Ben Larmans Lab of Precision Immunology. It builds off decades of work in the fields of genomics, proteomics, immunology, and bioinformatics. Our assay was engineered to enable best-in-class turnaround times and cost. With a team of experienced professionals and a state-of-the-art facility, we...

Antibody ,immunology,biotechnology,services,viruses,allergens,peptides,proteomics,autoimmune,infectious diseases,and vaccines

Infinity bio, inc operates in the Biotechnology research industry.

Infinity bio, inc's revenue is 11m - 100m

Infinity bio, inc has 11 - 50 employees.